Liaoning Meizilin

Liaoning Meizilin Pharmaceutical Co., Ltd. is a comprehensive pharmaceutical enterprise based in the Benxi High-tech Industrial Development Zone, often referred to as the China Medicine Capital. Established in 2012, the company specializes in the research, development, and large-scale production of both chemical pharmaceuticals and traditional Chinese medicines. Its primary therapeutic focus is on respiratory health, with its flagship product being Compound Methoxyphenamine Capsules, widely used for treating bronchial asthma and chronic bronchitis. The company operates modern, GMP-certified manufacturing facilities capable of producing various solid dosage forms, including capsules and tablets. Meizilin is recognized as a key high-tech enterprise in Liaoning Province, dedicated to providing high-quality respiratory and cardiovascular treatments to the domestic Chinese market.